COLAR
Columbus Acquisition Corp/Cayman Islands
No data for this timeframe.
Vol
SEC Reports5
Recent Activity
Jun 1, 2026
SEC
Columbus Acquisition Corp (COLAR) received a Nasdaq notice on May 22, 2026, that its Market Value of Listed Securities (
8-K — Impact 4/10
May 22, 2026
SEC
Columbus Acquisition Corp extended its business combination deadline from May 22, 2026 to June 22, 2026 by depositing $5
425 — Impact 4/10
May 22, 2026
SEC
Columbus Acquisition Corp deposited $50,000 into its trust account to extend its deadline to complete a business combina
8-K — Impact 4/10
Latest Reports
NEUTRAL
8-K
4/10
Columbus Acquisition Corp (COLAR) received a Nasdaq notice on May 22, 2026, that its Market Value of Listed Securities (
Jun 1, 2026
NEUTRAL
425
4/10
Columbus Acquisition Corp extended its business combination deadline from May 22, 2026 to June 22, 2026 by depositing $5
May 22, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
5 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 5 neutral. Avg impact: 4.0/10.
NEUTRAL
8-K
4/10
Columbus Acquisition Corp (COLAR) received a Nasdaq notice on May 22, 2026, that its Market Value of
Jun 1, 2026
NEUTRAL
425
4/10
Columbus Acquisition Corp extended its business combination deadline from May 22, 2026 to June 22, 2
May 22, 2026
NEUTRAL
8-K
4/10
Columbus Acquisition Corp deposited $50,000 into its trust account to extend its deadline to complet
May 22, 2026
NEUTRAL
425
4/10
Columbus Acquisition Corp extended its deadline to complete an initial business combination by one m
Apr 24, 2026
NEUTRAL
8-K
4/10
Columbus Acquisition Corp extended its deadline to complete an initial business combination by one m
Apr 24, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.